Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cogent Biosciences (COGT) Depreciation & Amortization (CF): 2017-2024

Historic Depreciation & Amortization (CF) for Cogent Biosciences (COGT) over the last 8 years, with Dec 2024 value amounting to $2.5 million.

  • Cogent Biosciences' Depreciation & Amortization (CF) rose 300.00% to $68,000 in Q4 2021 from the same period last year, while for Dec 2021 it was $147,000, marking a year-over-year decrease of 79.58%. This contributed to the annual value of $2.5 million for FY2024, which is 8.70% up from last year.
  • Latest data reveals that Cogent Biosciences reported Depreciation & Amortization (CF) of $2.5 million as of FY2024, which was up 8.70% from $2.3 million recorded in FY2023.
  • In the past 5 years, Cogent Biosciences' Depreciation & Amortization (CF) ranged from a high of $2.5 million in FY2024 and a low of $147,000 during FY2021.
  • Moreover, its 3-year median value for Depreciation & Amortization (CF) was $2.3 million (2023), whereas its average is $1.9 million.
  • Its Depreciation & Amortization (CF) has fluctuated over the past 5 years, first crashed by 79.58% in 2021, then surged by 444.22% in 2022.
  • Over the past 5 years, Cogent Biosciences' Depreciation & Amortization (CF) (Yearly) stood at $720,000 in 2020, then crashed by 79.58% to $147,000 in 2021, then skyrocketed by 444.22% to $800,000 in 2022, then spiked by 187.50% to $2.3 million in 2023, then climbed by 8.70% to $2.5 million in 2024.